Historical record - last NADAC effective date: 5/20/2015
Product Information
ROBITUSSIN LONG-ACTING LIQ is a brand product labeled by Haleon US Holdings LLC, priced at $0.0375 per ML under NDC 00031869312. Its NADAC has been published 97 times since Nov 28, 2013.
Strength
2; 15 mg/10mL; mg/10mL
Manufacturer
Haleon US Holdings LLCNDC
00031869312
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
5/20/2015
Active Ingredients
CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/1/2004
Pharmacological Classes
Price Statistics
The NADAC for ROBITUSSIN LONG-ACTING LIQ has been published 97 times since Nov 28, 2013, and over the history we have for it it has risen 3.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0375 per ML |
|---|---|
| All-time high | $0.0390 (Apr 15, 2015) |
| All-time low | $0.0364 (Nov 28, 2013) |
| Median price | $0.0375 |
| Average price | $0.0372 |
| Largest weekly change | -5.5% (Apr 22, 2015) |
| Weeks tracked | 97 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+3.1%
Last surveyed Sep 30, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the chlorpheniramine maleate, dextrometrorphan HBr market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
chlorpheniramine maleate, dextrometrorphan HBr market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROBITUSSIN LONG-ACTING LIQ?
The current National Average Drug Acquisition Cost (NADAC) for ROBITUSSIN LONG-ACTING LIQ, manufactured by Haleon US Holdings LLC, is $0.0375 per ML (NDC 00031869312), effective Sep 30, 2015.
How has the price of ROBITUSSIN LONG-ACTING LIQ changed over time?
Over the history we have for it, the NADAC for ROBITUSSIN LONG-ACTING LIQ has risen 3.1%. It has been tracked across 97 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROBITUSSIN LONG-ACTING LIQ?
Since Nov 28, 2013, the NADAC for ROBITUSSIN LONG-ACTING LIQ has ranged from a low of $0.0364 (Nov 28, 2013) to a high of $0.0390 (Apr 15, 2015), with a median of $0.0375 per ML.
Are there cheaper alternatives to ROBITUSSIN LONG-ACTING LIQ?
No other NADAC-published product currently shares the active ingredient and strength of ROBITUSSIN LONG-ACTING LIQ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROBITUSSIN LONG-ACTING LIQ?
ROBITUSSIN LONG-ACTING LIQ (NDC 00031869312) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.